We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mporium Group Plc | LSE:MPM | London | Ordinary Share | GB00BGDW0L56 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
15/4/2009 15:41 | I think I'll pass..this looks well dodgy...10 small buys here today and no news does not justify this change in the price....smells of a Ramp to me... | monkey puzzle | |
15/4/2009 15:26 | Looks like others agree to! up 15% currently! | themoneymonster2 | |
15/4/2009 13:57 | TMM2 I totally agree with you, these seem very undervalued given cash and pipeline. | simonparker5 | |
15/4/2009 13:21 | Cash of £7 million against market cap of £2.5 million, i know what you are all going to say, they will need cash to bring their product to market, not if someone takes them out! | themoneymonster2 | |
01/4/2009 14:51 | Norwegian Blue? | monkey puzzle | |
26/3/2009 13:49 | NAZ, you also missed my suggestion on AFR,which has since doubled!! | mikey34 | |
26/3/2009 10:52 | Hugepants ,Thank you for the tip my friend ,but i missed the boat again ,i did not buy them what an idoit , i kept my mpm shares , | naz4 | |
18/3/2009 14:07 | Neuropharm(NPH) released results yesterday. They had over 30p net cash at end December. Currently can buy at under 7p. They have cut cash burn and will be issuing a strategy update shortly. MPM need to issue a strategy update because they clearly dont have enough funds to take their remaining drugs pipeline to market. And raising funds in this market is well nigh impossible | hugepants | |
18/3/2009 13:29 | naz, If you're interested in other stuff in this sector,GWP has had some good news recently and could do really well if your patient. I personally think that some of the smaller oil producers/explorers have been massively oversold and could have lots of upside.....I bought into AFR yesterday,........bu | mikey34 | |
18/3/2009 08:55 | for example mikey | naz4 | |
17/3/2009 18:14 | NAZ, All you can say is that the cash is currently more than the mkt cap....but the product is not going to make any money.Its just a question of what happens to their cash.I have watched for a couple of yrs and thankfully never bought and I just think there are much better bets now. | mikey34 | |
16/3/2009 11:15 | does anybody belive these will ever recover,are they worth a buy ,or just putting money in a worthless pit,please an honest opinion | naz4 | |
13/3/2009 07:37 | Good question. MPM dont have enough cash to fund their remaining drug development progamme to completion. Its at too early a stage. Similar to Neuropharm (NPH) which has a market cap of £1.85M yet had £12.5M net cash at end of June 08. | hugepants | |
12/3/2009 11:21 | why have they not made a statement ,which direction from here | naz4 | |
12/3/2009 08:33 | £7 million cash against a market cap of under £3 million is ridiculous! You can actually buy at 4.8p! | themoneymonster2 | |
18/2/2009 09:16 | MPM had £9m in cash at the end of Sept (as stated in interims) and at the end of Jan they had £7m....a burn rate of about £0.5m per month.....so that would give them about a year to go....and fwiw their market cap is only £3m...... | monkey puzzle | |
17/2/2009 13:21 | They did well to get 4p...... | monkey puzzle | |
17/2/2009 13:17 | someone sold 169000 shares at 4p | terryvern | |
17/2/2009 12:12 | why the massive fall ,what,s going on | naz4 | |
10/2/2009 13:02 | leadersoffice you really should not have listened to harry punter...well you live and learn... | spitfire3 | |
09/2/2009 21:00 | Naz4 - failed science but cash. Someone may pick it up but for the cash but to have to reprofile this for another indication would take years and lots of funding. its toast | will t | |
05/2/2009 17:02 | any opinion on where do you thing they will go from here ,chances of a merger with another drug company ,which may be specailising in eiplipsy ,any view. | naz4 | |
03/2/2009 15:31 | and another piece of AIM shyte bites the dust.....shame is that it's the PIs who get burnt in the process and no one give a toss...keeps on happening...always take care before buying anything listed on AIM... | monkey puzzle |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions